The global robotic surgery market size is calculated at USD 13.79 billion in 2025 and is expected to reach around USD 54.66 billion by 2034, growing at a CAGR of 16.54% for the forecasted period.
The global robotic surgery market size is calculated at USD 13.79 billion in 2025 and is expected to reach around USD 54.66 billion by 2034, growing at a CAGR of 16.54% for the forecasted period.
DELRAY BEACH, Fla., July 3, 2025 /PRNewswire/ --
What's fueling the shift from sterilization to scalability?
The global single-use surgical instruments market, valued at US$5.60 billion...
SAN FRANCISCO, July 3, 2025 /PRNewswire/ -- Nova Ukraine is proud to announce a new milestone: Platinum Seal of Transparency from Candid. This is the highest...
Washington-based critical access hospital dials into Medline's supply chain resilience and vast product portfolio
NORTHFIELD Ill., July 2, 2025 /PRNewswire/ -- Medline today announced a new Prime...
SAN DIEGO, July 2, 2025 /PRNewswire/ -- A new prospective study published in BMC Cancer demonstrates that a novel blood-based multi-omics test, SeekInClarity, can accurately...
AdventHealth purchased Bond Clinic's comprehensive multi-specialty operations and care sites.
ALTAMONTE SPRINGS, Fla., July 2, 2025 /PRNewswire/ -- Bond Clinic, a physician group comprised of...
Over 40 Years of Dedicated Partnership and Growth in Singapore's Transformation Journey
SINGAPORE, July 2, 2025 /PRNewswire/ -- Johnson Controls (NYSE: JCI), the global leader for smart,...
CHILLICOTHE, Ohio, July 1, 2025 /PRNewswire/ -- Patient care and access at Adena Health continues to benefit from the strength of its graduate medical education...
Novo Holdings led Kate Farms' Series C financing in 2022 and supported its continued growth as the company's largest institutional investor
Transaction highlights the Planetary...
OMAHA, Neb., July 01, 2025 (GLOBE NEWSWIRE) -- TeleVox, the industry-leading provider of omnichannel patient relationship management platforms, is addressing the outreach gap in patient care with the launch of the Planned Outreach Program. This new solution, integrated within the award-winning TeleVox Practice Edition platform, is designed to drive patient engagement results for small practices with smart, automated outreach.
EINDHOVEN, the Netherlands, July 01, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and other movement disabilities, today announced the submission of two major regulatory applications for its ARC-EX System. The Company has submitted a 510(k) application to the US Food and Drug Administration (FDA) seeking clearance to expand its indication for home use. In parallel, ONWARD has filed an application with the notified body for CE Mark certification in accordance with the European Union Medical Device Regulation (MDR) to enable commercialization of the ARC-EX System in the EU. Completed in June, these submissions represent significant milestones as the Company advances its mission to bring breakthrough therapies to people with SCI around the world.
Northwest Indiana-based integrated health system to leverage Medline to drive product and process standardization
NORTHFIELD, Ill., June 30, 2025 /PRNewswire/ -- Today, Medline announced it has entered into...